Karaarslan, NumanYılmaz, IbrahimAkgün, Feride SinemCaliskan, TezcanÖzbek, HanefiAtes, Özkan2024-07-122024-07-1220201019-514910.5137/1019-5149.JTN.23064-18.12-s2.0-85097393920https://doi.org/10.5137/1019-5149.JTN.23064-18.1https://search.trdizin.gov.tr/yayin/detay/409745https://hdl.handle.net/20.500.12415/6909AIM: To discuss the management of patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH) developing after subarachnoid hemorrhage, in a comparative manner in the light of the literature. MATERIAL and METHODS: Without country or language restrictions, articles with high evidential value found in electronic databases were compared to our patients' data. RESULTS: After the literature review, three articles were included for systematic evaluation. Desmopressin was administered to the patients for the treatment of hyponatremia, volume contraction, and negative sodium balance caused by SIADH. However, it was not used for preventing re-bleeding. CONCLUSION: To prevent the development of this complication (SIADH), the use of desmopressin, an analogue of vasopressin, is important in routine clinical practice.eninfo:eu-repo/semantics/closedAccessDesmopressinSodiumSubarachnoid HemorrhageSyndrome Of Inappropriate Antidiuretic Hormone SecretionUrine OsmolalityArticle792629694665Q378740974530WOS:000593272300001Q4